Lessons in Blood Cancer: How Far We Have Come: Mantle Cell Lymphoma

Doctors and researchers have been studying cancer for generations. Thanks to pioneers in science and tireless dedication, we have made great strides in diagnosis, treatment, and the quest for cures. But we need to understand where we started to learn how to get where we are headed. Join us as we explore the history of blood cancer and highlight just how far we’ve come.

Speaker
Jacob D. Soumerai, MD
Assistant Professor of Medicine, Harvard Medical School
Center for Lymphoma, Massachusetts General Cancer Center
Boston, Massachusetts

Support provided by Adaptive Biotechnologies Corp; AstraZeneca Pharmaceuticals LP; and Eli Lilly and Company.

[aaronrhodes]

Amazing video it really gives me hope for the future.I wish I had come across this a couple of years ago before I received my treatment.

[cn-wkcx]

What happens if you have TP53 mutation in mantle cell lymphoma. Do these treatments work?